impact factor
logo
 

Brief Papers

 

Intracellular NF-kB-decrease and IKBα increase in human macrophages following CTLA4-Ig treatment


, , , , , ,

 

CER6809
2013 Vol.31, N°6
PI 0943, PF 0946
Brief Papers

Free to view
(click on article PDF icon to read the article)

PMID: 24295474 [PubMed]

Received: 23/07/2013
Accepted : 12/11/2013
In Press: 02/12/2013
Published: 20/12/2013

Abstract

OBJECTIVES:
The transcription factor NF-kB is involved in the expression of several genes linked to the immune response, including those of pro-inflammatory cytokines. We investigated cytokine production and NF-kB expression following CTLA4-Ig (abatacept) treatment of cultured human macrophages.
METHODS:
Human THP1 cells, differentiated in macrophages, were treated with CTLA4-Ig (100, 500 μg/ml; 3,12,24 hours). Quantitative RT-PCR analysis (qRT-PCR) of mRNA for NF-kB, IKBα and for IL-6, TNF-α, IL-1β, was performed after 3 and 12 hours from treatment. Western blot (WB) analysis for NF-kB and IKBα was performed after 24 hours from treatment.
RESULTS:
NF-kB gene expression was significantly downregulated (p<0.05), at 3 and 12 hours from CTLA4-Ig treatment, vs. untreated cells (cnt). IKBα resulted significantly increased vs. cnt (p<0.05), at 12 hours from CTLA4-Ig [500 μg/ml] treatment. After 3 hours, CTLA4-Ig [100 μg/ml] induced a significant decrease of TNF-α and IL-6 (p<0.05), vs. cnt and CTLA4-Ig [500 μg/ml] further reduced TNF-α (p<0.001), vs. cnt. After 12 hours from CTLA4-Ig treatment, a significant downregulation for IL-6 and IL1β expression (p<0.001), vs. cnt, was still evident. Results were confirmed by WB.
CONCLUSIONS:
NF-kB pathway seems to be implicated in the CTLA4-Ig modulation of macrophage cytokine expression. NF-kB expression resulted downregulated while its cytoplasmatic inhibitor IKBα was increased.

Rheumatology Article